MedPath

Health and Early Life Microbiota

Conditions
Allergy
Noncommunicable Diseases
Child Development
Growth
Overweight
Infectious Disease
Registration Number
NCT03996304
Lead Sponsor
University of Helsinki
Brief Summary

The aim of this cohort is to identify environmental, lifestyle and genetic factors that modify the human intestinal microbiota development during the first years of life, and to identify early microbiota features that associate to child health and well-being with focus on the development of allergic diseases and overweight.

Detailed Description

1055 healthy term infants born in 2016-2018 mainly at the capital region of Finland, and their parents. Fecal samples collected from infants and their parents. Electronic questionnaires on a weekly basis during the first 4 months of life, thereafter less frequently. Focus on diet, well-being and health and social manners. At one-year and at two-years comprehensive questionnaires including development and cognition. Parental stress evaluation included.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1055
Inclusion Criteria
  • General population, singleton pregnancy, at least one parent Finnish speaking
  • Willingness and ability of parents to consent for 2 year follow-up involving frequent electronic questionnaires and freezing of faecal samples at home
  • Infant born on gestational weeks 37-42 without known congenital defects

Exclusion Criteria

  • Preterm birth
  • Severe birth defect
  • Parents fail to activate the online questionnaires
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Longitudinal change of intestinal microbiota in early lifeFrom 3 weeks to 2 years after birth

Developmental trajectory of the intestinal microbiota, assessed with 16S rRNA gene amplicon and shotgun sequencing of fecal DNA to determine the changes in the intestinal microbiota composition, diversity and functionality from week 3 to weeks 6,9,12 and months 6,9,12,18 and 24 after birth.

Secondary Outcome Measures
NameTimeMethod
WeightAt 6,12,18 and 24 months after birth

Weight in kilograms.

Number of children with asthmaAt 2 years

Specialist/Physician-diagnosed asthma.

Number of children with allergic diseaseAt 2 years

Specialist/Physician-diagnosed wheeze, eczema/atopic dermatitis, allergic rhinitis, food allergy or atopy.

Child developmentAt 18 and 24 months after birth

By means of questionnaires and, on a randomly selected group of study subjects, developmental testing to assess cognitive, motor, socio-emotional and verbal development.

Number of respiratory tract infection episodesFrom birth to 2 years of age

Number of physician-diagnosed respiratory track infections.

GrowthAt 6,12,18 and 24 months after birth

Height in centimeters.

Trial Locations

Locations (1)

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki

🇫🇮

Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath